Berotralstat hydrochloride

Berotralstat hydrochloride Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Berotralstat hydrochloride is an oral plasma kallikrein inhibitor being developed by BioCryst Pharmaceuticals for the treatment of hereditary angioedema (HAE).

Berotralstat hydrochloride Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Berotralstat hydrochloride Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Aladdin Scientific		tp@aladdinsci.com	United States	52924	58
TargetMol Chemicals Inc.	+17819995354	marketing@targetmol.com	United States	19961	58
Chongqing jooe co., ltd	+86-19923400328 +86-15223382610	info@jooe.com	China	5647	58
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.	17702719238 18971495150;	sales@sun-shinechem.com	China	1057	64
SHANGHAI FORTUNE CHEMICAL TECHNOLOGY CO., LTD	13816107857	sales@fortunechem-sh.com	China	984	58
Hangzhou J&H Chemical Co., Ltd.	0571-87396432	sales@jhechem.com	China	14908	59
Changzhou Chenhong Biotechnology Co., Ltd.	+86-0519-85788828 +86-13775037613	sales@chemrenpharm.com	China	3935	58
Jinan Jiuli Biotechnology Co. , Ltd.	15865264761	486064515@qq.com	China	4715	58
TargetMol Chemicals Inc.	4008200310	marketing@tsbiochem.com	China	24989	58
Shanghai Tachizaki Biomedical Research Center	18014399201	sales@chemlab-tachizaki.com	China	2682	58

---

• Berotralstat hydrochloride
• Berotralstat dihydrochloride
• Berotralstat HCl
• 1809010-52-3